Two Sigma Investments, LP Sage Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 161,796 shares of SAGE stock, worth $927,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161,796
Previous 212,861 23.99%
Holding current value
$927,091
Previous $2.31 Million 49.55%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.02 - $13.08 $358,476 - $667,930
-51,065 Reduced 23.99%
161,796 $1.17 Million
Q2 2024

Aug 14, 2024
SELL
$10.58 - $17.9 $1.23 Million - $2.08 Million
-115,986 Reduced 35.27%
212,861 $2.31 Million
Q1 2024

May 15, 2024
BUY
$18.62 - $26.95 $1.49 Million - $2.15 Million
79,875 Added 32.08%
328,847 $6.16 Million
Q4 2023

Feb 14, 2024
BUY
$17.1 - $22.26 $4.26 Million - $5.54 Million
248,972 New
248,972 $5.4 Million
Q2 2023

Aug 14, 2023
SELL
$40.65 - $59.54 $1.72 Million - $2.52 Million
-42,251 Reduced 89.74%
4,832 $227,000
Q1 2023

May 15, 2023
BUY
$37.27 - $46.57 $752,481 - $940,248
20,190 Added 75.08%
47,083 $1.98 Million
Q4 2022

Feb 14, 2023
SELL
$32.2 - $43.61 $3.54 Million - $4.8 Million
-109,960 Reduced 80.35%
26,893 $1.03 Million
Q3 2022

Nov 14, 2022
SELL
$32.28 - $43.27 $1.26 Million - $1.69 Million
-39,172 Reduced 22.25%
136,853 $5.36 Million
Q2 2022

Aug 15, 2022
BUY
$27.52 - $37.99 $4.67 Million - $6.45 Million
169,706 Added 2685.65%
176,025 $5.69 Million
Q1 2022

May 16, 2022
BUY
$30.71 - $45.71 $194,056 - $288,841
6,319 New
6,319 $209,000
Q2 2021

Aug 16, 2021
SELL
$54.88 - $79.29 $8.28 Million - $12 Million
-150,794 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$70.65 - $96.76 $1.36 Million - $1.87 Million
19,301 Added 14.68%
150,794 $11.3 Million
Q4 2020

Feb 16, 2021
BUY
$58.41 - $89.06 $3.41 Million - $5.21 Million
58,449 Added 80.02%
131,493 $11.4 Million
Q3 2020

Nov 16, 2020
SELL
$41.13 - $62.45 $12.5 Million - $19 Million
-304,235 Reduced 80.64%
73,044 $4.46 Million
Q2 2020

Aug 14, 2020
SELL
$25.95 - $43.15 $2.64 Million - $4.39 Million
-101,746 Reduced 21.24%
377,279 $15.7 Million
Q1 2020

May 15, 2020
BUY
$26.15 - $77.24 $12.2 Million - $36.1 Million
467,722 Added 4138.03%
479,025 $13.8 Million
Q4 2019

Feb 14, 2020
BUY
$60.18 - $154.77 $680,214 - $1.75 Million
11,303 New
11,303 $816,000
Q4 2017

Feb 14, 2018
SELL
$60.72 - $167.34 $5.5 Million - $15.2 Million
-90,596 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$61.4 - $88.52 $5.56 Million - $8.02 Million
90,596
90,596 $5.64 Million

Others Institutions Holding SAGE

# of Institutions
218
Shares Held
46.4M
Call Options Held
847K
Put Options Held
188K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email